Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Baxter, Pharmaco (NZ) Ltd","Mesalazine, granules, 2 g sachets",Inflammatory bowel disease and similar,"Mesalazine, granules, 2 g sachets (Asacor,Pentasa)",Only if cost neutral or cost saving,Community and Hospital,Alimentary Tract and Metabolism
